Pancreatic Cancer Research

ResearcherTohoku UniversityNo recent work listed

Akira Horii

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3967-3291; OpenAlex author ID A5009665973. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 3 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 11

  1. TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study. Last author DOI 10.1007/s00595-023-02655-3↗
  2. Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2020.03.120↗
  3. Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer. Co-author DOI 10.1111/cas.14644↗
  4. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers. Last author DOI 10.1016/j.bbrc.2017.01.055↗
  5. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers. First author DOI 10.1016/j.canlet.2012.03.022↗
  6. Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1097/mpa.0000000000000106↗
  7. Molecular pathology of pancreatic cancer. First author DOI 10.1111/pin.12114↗
  8. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Last author DOI 10.1016/j.bbrc.2013.10.010↗
  9. The expression of S100A4 in human pancreatic cancer is associated with invasion. Last author DOI 10.1097/mpa.0b013e31828804e7↗
  10. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Last author DOI 10.1016/j.bbrc.2012.10.048↗
  11. Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activ… First author DOI 10.1016/j.bbrc.2011.06.121↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michiaki Unno · 7 shared papers, 2011–2023 · strength 0.58
  2. Fuyuhiko Motoi · 7 shared papers, 2011–2023 · strength 0.58
  3. Shinichi Fukushige · 6 shared papers, 2011–2023 · strength 0.43
  4. Yuriko Saiki · 6 shared papers, 2012–2023 · strength 0.43
  5. Yakefujiang Abudurexiti · 2 shared papers, 2020 · strength 0.24
  6. Tatsuo Hata · 2 shared papers, 2020 · strength 0.24
  7. Kanchan Chakma · 2 shared papers, 2020 · strength 0.24
  8. Shinichi Fukushige · 2 shared papers, 2020 · strength 0.24
  9. Sho Fujiwara · 1 shared paper, 2023 · strength 0.19
  10. Makoto Sunamura · 5 shared papers, 2011–2017 · strength 0.18
  11. Akihiro Yamamura · 3 shared papers, 2013–2017 · strength 0.12
  12. Shinichi Egawa · 3 shared papers, 2011–2013 · strength 0.08
  13. Hiroki Nagase · 2 shared papers, 2012–2013 · strength 0.06
  14. Simona Dima · 1 shared paper, 2014 · strength 0.04
  15. Dana Cucu · 1 shared paper, 2014 · strength 0.04
  16. Dan Gabriel Duda · 1 shared paper, 2014 · strength 0.04
  17. Irinel Popescu · 1 shared paper, 2014 · strength 0.04
  18. Hideyuki Shimizu · 1 shared paper, 2011 · strength 0.03
  19. Kazuhiro Morishita · 1 shared paper, 2013 · strength 0.03
  20. Hitoshi Sekine · 1 shared paper, 2012 · strength 0.03
  21. Nobukazu Tsukamoto · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.